1024 related articles for article (PubMed ID: 25237838)
1. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
2. Lipid-coated polymeric nanoparticles for cancer drug delivery.
Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
[TBL] [Abstract][Full Text] [Related]
3. Advances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery.
Liu Y; Xie X; Chen H; Hou X; He Y; Shen J; Shi J; Feng N
Nanomedicine; 2020 Oct; 29():102237. PubMed ID: 32534047
[TBL] [Abstract][Full Text] [Related]
4. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
7. Polymer-lipid hybrid systems used as carriers for insulin delivery.
Grigoras AG
Nanomedicine; 2017 Nov; 13(8):2425-2437. PubMed ID: 28821465
[TBL] [Abstract][Full Text] [Related]
8. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
Kahraman E; Güngör S; Özsoy Y
Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.
Pathak K; Keshri L; Shah M
Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401
[TBL] [Abstract][Full Text] [Related]
10. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery.
Date AA; Vador N; Jagtap A; Nagarsenker MS
Nanotechnology; 2011 Jul; 22(27):275102. PubMed ID: 21606564
[TBL] [Abstract][Full Text] [Related]
12. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
Garcês A; Amaral MH; Sousa Lobo JM; Silva AC
Eur J Pharm Sci; 2018 Jan; 112():159-167. PubMed ID: 29183800
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based nanocarriers for breast cancer treatment - comprehensive review.
Talluri SV; Kuppusamy G; Karri VV; Tummala S; Madhunapantula SV
Drug Deliv; 2016 May; 23(4):1291-305. PubMed ID: 26430913
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Review on Role of Nanoparticles in Therapeutic Delivery of Medicine.
Rathor S; Bhatt DC; Aamir S; Singh SK; Kumar V
Pharm Nanotechnol; 2017; 5(4):263-275. PubMed ID: 29141578
[TBL] [Abstract][Full Text] [Related]
15. An alternative choice of lidocaine-loaded liposomes: lidocaine-loaded lipid-polymer hybrid nanoparticles for local anesthetic therapy.
Wang J; Zhang L; Chi H; Wang S
Drug Deliv; 2016 May; 23(4):1254-60. PubMed ID: 26881926
[TBL] [Abstract][Full Text] [Related]
16. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
Eur J Pharm Biopharm; 2017 Jan; 110():58-69. PubMed ID: 27789359
[TBL] [Abstract][Full Text] [Related]
19. Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.
Sgorla D; Bunhak ÉJ; Cavalcanti OA; Fonte P; Sarmento B
Expert Opin Drug Deliv; 2016 Sep; 13(9):1301-9. PubMed ID: 27110648
[TBL] [Abstract][Full Text] [Related]
20. Preparation of drug-loaded polymeric nanoparticles and evaluation of the antioxidant activity against lipid peroxidation.
Pohlmann AR; Schaffazick SR; Creczynski-Pasa TB; Guterres SS
Methods Mol Biol; 2010; 610():109-21. PubMed ID: 20013175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
